Navigation Links
Encorium Reports Second Quarter 2010 Financial Results
Date:8/17/2010

2009, respectively.  SG&A expenses for the first six months of 2010 were $3.8 million, or 56% of net revenue, compared to $4.3 million, or 48% of net revenue, for the prior year period.  

The Company reported a net loss from continuing operations for the six months ended June 30, 2010 of $2.7 million, or $(0.80) per diluted share, as compared to a net loss from continuing operations of $1.8 million, or $(0.72) per diluted share for the six months ended June 30, 2009.  

We anticipate that will meet our cash requirements through September 2011, assuming we are able to fully implement our current costs cutting initiatives, we are able to win additional contracts during fiscal 2010 and we are able to maintain our current customer contracts.  In the event we are unable to do so, in order for the Company to continue as a going concern we will be required to obtain additional capital or significantly reduce our operating costs.  Encorium's balance sheet at June 30, 2010 reflected cash and cash equivalents of $176 thousand.  Net cash used in operations for the six months ended June 30, 2010 was approximately $853 thousand.

On July 19, 2010, the Company acquired Progenitor Holding AG, a European headquartered emerging market clinical research organization providing international drug development services in emerging market regions.  The consideration for the acquisition was a combination of cash and stock valued at $2.0 million, plus earn-out consideration of $1.8 million.

Dr. Kai Lindevall, Chief Executive Officer stated, "We are pleased to see the improved results over the first quarter as a result of recent contract awards and our continued focus on cost cutting.  With the acquisition of Progenitor we have expanded our service offerings in key emerging markets, including Latin America, India and Asia Pacific, which was a key step to realizing our goal of becoming the world's leading vaccine CRO.  
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
3. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
4. Encorium Re-Appoints Dr. Kai Lindevall as Chief Executive Officer and Appoints Current Director, Shahab Fatheazam, Chairman of the Board
5. Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
6. Encorium Group, Inc. Acquires Progenitor International Research, a Vaccine Focused Emerging Market CRO
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Spherix Reports Second Quarter Earnings
9. Tapestry Reports Second Quarter 2007 Results
10. Callisto Reports on Second-Quarter 2007 Milestones
11. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and ... consumers, employers and government health plans $23.3 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  BD Life ... Company) (NYSE: BDX ), a leading ... innovative company focused on enabling high-resolution biology, today ... unique solutions for highly multiplexed cell isolation and ... are promoting BD,s powerful BD FACS™ single-cell sorting ...
(Date:2/26/2015)... 2015  Lyric Pharmaceuticals Inc. today announced the initial ... million. The financing, co-led by RiverVest Venture Partners, Sante ... Venture Partners. Lyric is a clinical-stage ... , M.D., M.B.A., President & Chief Executive Officer and ... In 2014, Lyric closed a seed financing round of ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... to respond to agency during first quarterKENILWORTH, N.J., Jan. ... today announced that the U.S. Food and Drug Administration ... (asenapine) sublingual tablets in the acute treatment of schizophrenia ... or mixed episodes associated with bipolar I disorder in ...
... Clinical Trial for the Treatment of Pediatric Eosinophilic Esophagitis ... Cephalon, Inc . (Nasdaq: CEPH ) ... today announced that the companies have signed an agreement ... capital stock of Ception. Under the terms of ...
Cached Medicine Technology:U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 3Cephalon Signs Option Agreement to Acquire Ception Therapeutics 4
(Date:2/27/2015)... The Radiology Business Management Association ... class of Fellows — one of the most highly ... , Since 2009, the RBMA Fellowship program has ... members to the Association and the profession. Fellow of ... Fellow candidate must meet a very high standard for ...
(Date:2/27/2015)... 27, 2015 With Spring’s wet weather on ... condition of their crawl spaces in mind. The latest ... most common FAQs regarding crawl space conditions and repairs. ... to owners that are confused as to how water is ... of the most common ways is through cracks in the ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Is it reasonable ... youth football practices and games, and possible to do so ... other youth sports might be at high risk for concern ... some of the issues being addressed by two introductory bills, ... of a hearing last month in New York City. ...
(Date:2/27/2015)... 2015 Prescription Drug “Take-Back” events ... Enforcement Agency (DEA). Today, local law ... utilize the “Take-Back” guidelines for the proper disposal ... Eufaula Prescription Drug Disposal Event , The McInstosh ... Eufaula, Oklahoma as the “Take-Back” site for the ...
(Date:2/27/2015)... If there is one thing that drives parents into ... outbreak at their child’s school. While head lice are not ... short of a nightmare for many parents as they see ... within their child’s classroom. Just when they think the problem ... , Local lice removal company, Lice Troopers , reports ...
Breaking Medicine News(10 mins):Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Crawl Space FAQs are Answered in Clean Crawls Latest Article 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 3Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:Anxiety over head lice among Miami parents as surge in head lice cases reported by local lice removal company Lice Troopers 2
... the newly incorporated subsidiary of Genomatix Software GmbH, has announced ... with the NCI/NIH for the fourth consecutive year. This years ... renewal was executed entirely between the US company and the ... pleased with our progress in putting the US company on ...
... by Rice University Psychology Professor Tony Ro has published ... known as synesthesia, in which stimulation of one sensory ... sensory pathway. , Ro,s paper, Feeling Sounds After a ... Neurology, the official journal of the American Neurological Association. ...
... the Centre for Addiction and Mental Health (CAMH) have ... of head and neck cancers, showing that people who ... , According to CAMH Principal Investigator Dr. Jrgen Rehm, ... and an increased risk for cancer of the esophagus, ...
... Projects, REDWOOD CITY, Calif., Sept. 26 ... that it has obtained,commitments from several institutional investors ... stock and warrants to purchase,approximately 2.6 million shares ... $23.7 million. The investors have agreed to purchase ...
... this valuable form of care, experts say , ... care have issued new "performance measures" meant to boost ... too many heart attack patients aren,t getting the benefit ... will also set standards of excellence for these programs ...
... Neb., Sept. 26 The close of summer traditionally,marks ... the advent of fall,and holiday baking seasons. This year, ... obesity -- healthier cooking is a growing,trend. A study ... the biggest gains in kids, body mass index occur ...
Cached Medicine News:Health News:Research at Rice may help explain aspects of synesthesia 2Health News:Research at Rice may help explain aspects of synesthesia 3Health News:Alcohol and cancer: is drinking the new smoking? 2Health News:Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing 2Health News:Heart Attack Survivors Benefit From Rehab 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 3Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 4
... liquid handling capability allows you to ... 5 nanoliters. Precision robotics and flexible ... so youll hit your target every ... without an air gap, providing increased ...
... System Genesis NPS based on the well-known ... to miniaturize your assays for high throughput ... direct dilutions., Furthermore it is an ... gene expression analysis, gene mapping, SNP detection ...
... Automatic dispenser for low volumes. Dispenses volumes ... -well format. Fast throughput of less than ... The dispenser features an intuitive user interface ... used to dispense liquids and suspensions, beads, ...
... dispensing of reagents, buffers and solvents for ... through eight nozzle manifolds for fast throughput. ... dispensing one, two or four reagents into ... from 200 nL to 2.0 mL with ...
Medicine Products: